- Home
- PRO vs BBNX Comparison
PRO vs BBNX Comparison
Compare PRO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRO | BBNX |
|---|---|---|
| Founded | 1985 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2007 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PRO | BBNX |
|---|---|---|
| Price | $23.25 | $29.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $24.54 | ★ $28.55 |
| AVG Volume (30 Days) | ★ 1.2M | 890.9K |
| Earning Date | 10-27-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $351,682,000.00 | $88,570,000.00 |
| Revenue This Year | $10.50 | $52.13 |
| Revenue Next Year | $10.86 | $36.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 8.92 | ★ 67.01 |
| 52 Week Low | $13.61 | $8.89 |
| 52 Week High | $29.84 | $32.71 |
Technical Indicators
Market Signals| Indicator | PRO | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 76.66 | 53.18 |
| Support Level | $23.06 | $27.86 |
| Resistance Level | $23.20 | $30.64 |
| Average True Range (ATR) | 0.05 | 1.76 |
| MACD | -0.04 | -0.27 |
| Stochastic Oscillator | 95.24 | 35.62 |
Price Performance
Historical ComparisonAbout PRO PROS Holdings Inc.
Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.